title: Phlebitis due to irinotecan.
authors.forename: F
authors.initials: F
authors.lastname: Tas
authors.forename: H
authors.initials: H
authors.lastname: Karagol
authors.forename: A
authors.initials: A
authors.lastname: Karadeniz
authors.forename: E
authors.initials: E
authors.lastname: Topuz
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D001132:Arm; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006801:Humans; D007262:Infusions, Intravenous; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010689:Phlebitis / Q000139:chemically induced*; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin